https://www.selleckchem.com/products/abt-199.html
Fetal exposure to maternal GDM increases offspring risk for adult-onset metabolic syndromes. Epigenetic modifications such as DNA methylation are modulators for fetal metabolic programming and susceptibility to adult-onset disease. This study investigates genome-wide DNA methylation in GDM exposed cord blood and placenta. Oral glucose tolerance testing between 24 and 28weeks of pregnancy was used to determine severity of glucose intolerance. We measured DNA methylation (DNAm) using the Illumina Infinium 450K array in 42 fetal cord blood
Tycka om
Kommentar
Dela med sig
